GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 351 - 375 of 4050 in total
Antibody Patient Onset (days) ▲ Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgM Patient 3 -180 mild
G54064FW
85
IgM Patient 3 -180 mild
G57449OF
71
IgM Patient 3 -180 mild
G58547FH
82
IgM Patient 3 -180 mild
G58969RU
78
IgM Patient 3 -180 mild
G60761LT
11488
IgM Patient 3 -180 mild
G61399NC
106
IgM Patient 3 -180 mild
G61751GZ
94
IgM Patient 3 -180 mild
G62222PE
6891
IgM Patient 3 -180 mild
G62826CL
78
IgM Patient 3 -180 mild
G63074CQ
64
IgM Patient 3 -180 mild
G64669AQ
1075
IgM Patient 3 -180 mild
G65889KE
130
IgM Patient 3 -180 mild
G66937TJ
134
IgM Patient 3 -180 mild
G67045LB
88
IgM Patient 3 -180 mild
G68461PT
6322
IgM Patient 3 -180 mild
G68703KI
7539
IgM Patient 3 -180 mild
G69912LP
7090
IgM Patient 3 -180 mild
G71142DF
737
IgM Patient 3 -180 mild
G71469XA
131
IgM Patient 3 -180 mild
G72424VO
84
IgM Patient 3 -180 mild
G72739GY
56
IgM Patient 3 -180 mild
G73271MD
80
IgM Patient 3 -180 mild
G75896PD
161
IgM Patient 3 -180 mild
G76355TG
110
IgM Patient 3 -180 mild
G76615YG
6196

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024